DENVER--(BUSINESS WIRE)--April 21, 2006--Myogen, Inc. (Nasdaq: MYOG - News), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders, today announced that it will report 2006 first quarter results the morning of Monday, May 8, 2006.
